Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00671970
Brief Title: Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)

First Submitted : January 29, 2008
First Submitted that Met QC Criteria : May 5, 2008
First Posted : May 6, 2008 (Estimate)

Results First Submitted : December 28, 2012
Results First Submitted that Met QC Criteria : March 29, 2013
Results First Posted : May 13, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : March 29, 2013
Last Update Posted : May 13, 2013 (Estimate)